Elevated level of expression of CDK8, HGS, MET, PRKDC, PRPF6, and PTK2 is associated with different stages of CRC, whereas PRKCZ is expressed at low levels in CRC patients as compared to normal controls (Fig. 8). This evidence concerns the gene MET and colorectal carcinoma.